Abstract
Corrigendum to ‘Experience with ruxolitinib in the treatment of polycythaemia vera’ by Samah Alimam and Claire Harrison, Therapeutic Advances in Hematology 2017, 8(4): 139–151. DOI: 10.1177/2040620717693972.
The value of “Revised WHO criteria” should be read as “1. Haemoglobin >16.5 g/dl in men”.